The Ostomy Drainage Bags Market is expected to register a CAGR of 4.5% during the forecast period.
According to a research study by Dario D’Antonio et al., published in SN Comprehensive Clinical Medicine Journal August 2020, several surgical societies provided specific procedures and guidelines, including triaging pathways and telemedicine (TM) during times of high disease pressure. Moreover, the presence of a stoma, even in a non-emergent setting, has a great impact on patient's quality of life, so medical and psychological support are needed, especially at the beginning of the stoma experience.
In addition, according to a research study by Vincenza Paola Dinuzzi et al., published in Wound Management & Prevention Journal January 2021, stated that reorganization of stoma care services, including the availability of telemedicine, did not result in a decrease in the number of consultations provided. The results suggest that stoma care services using telemedicine may provide valid support for patients with an ostomy in the future.
Some of the factors that are driving the market's growth include increasing geriatric population, rising incidence of inflammatory bowel disease, Crohn's disease, colorectal and bladder cancer cases. For instance, according to the World Ageing 2019 report, in 2019, there were around 703 million people aged 65 years or more in the world. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019. The proportion is projected to rise further to 16% by 2050. By 2050, 1 in 6 people in the world will be over the age of 65 years, up from 1 in 11 in 2019.
Furthermore, according to Nicolas Patel, in an article published in 2020, inflammatory bowel disease is most prevalent in South America at approximately 21%, and least prevalent in Southeast Asia at 7%. In the United States, Canada, and Israel, IBS symptoms are 1.5 to 2 times more prevalent among women than men.
Increasing research and development activities in the development of novel products is contributing to the market growth. For instance, in August 2019, United Ostomy Associations of America, Inc., (UOAA) 7th National Conference was held on 8 and 9 August, 2019 at Pennsylvania on ‘discover a world of ostomy product’. The conference was visited by ostomy producers, accessories producers, retailers, fashion specialists and associated assistance organizations. However, factor such as reimbursement issues acting as a restraining factor to the market growth.
Key Market Trends
Colostomy Bags Segment is Expected to a Hold Significant Market Share Over the Forecast Period
In colostomy, the colon is linked with the stoma, thereby bypassing the anus and rectum. A colostomy bag is a small pouch, used for closed colostomy procedures. It is used for the collection of waste from a surgically diverted biological system. There are mainly two types of colostomy bags, the disposable types, and the re-useable bags. Disposable bags are the more preferred ones, due to certain advantages, like removing and disposing of them is quite easy and they are easy to carry everywhere.
According to a research study by F Marino et al., published in British Journal of Surgery June 2020, during the COVID-19 pandemic, numbers of patients with colorectal cancer needing a stoma are likely to increase. The recommendations of scientific societies encourage interventions with a lower risk of complications, short recovery time and less likelihood of ICU admission, especially those who test positive for COVID-19.
Furthermore, the COVID-19 pandemic is worsening disability in stoma patients. Only good synergy between correct stoma care practices and adequate government provisions can help overcome this challenging situation.
Moreover, the use of the demand for these bags has increased over the years due to the increasing incidence of Inflammatory Bowel Diseases (IBD). For instance, according to the research study by Thomas Joshua Pasvol et al., published in BMC Journal August 2020, in United Kingdom, the incidence of inflammatory bowel disease (IBD), Crohn’s disease (CD) and ulcerative colitis (UC) was found to be 28.6, 10.2 and 15.7/100,000 population, respectively. Moreover, in adolescents aged 10-16 years, incidence of inflammatory bowel disease (IBD) was increased from 13.1 in 2000 to 25.4/100,000 population in 2018, respectively.
Technological advancements in the developmnent of novel devices is also boosting the segment growth. For instance, according to a resarch study by P.-A. Lehur et al., published in Techniques in Coloproctology Journal August 2019, the study conducted to assess new type of two-piece appliance including a base plate and a “capsule cap” (CC) composed of a capsule cover and a folded collecting bag. The study results found that new device has provided an increased control over bowel emptying at no risk in half of the trial population suggesting that an alternative approach to bag wearing is achievable. Hence, owing to above mentioned factors it is expected to drive the segment growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
Some of the factors which are driving the market growth in North America region include increasing incidence of Inflammatory Bowel Disease and Crohn's Disease, rapidly growing aging population, rising colorectal and bladder cancer and presence of key market players in the region.
In the United States, the ostomy community is concerned about how the COVID-19 outbreak is affecting their daily lives, health, support networks, and access to ostomy supplies. In Current COID-19 situation, United Ostomy Associations of America, Inc., (UOAA), recommends all individuals consult with their own primary care physicians with questions concerning their risk factor or if they exhibit any symptoms. In addition, as of March 4, 2020 none of the manufacturers reported any issues in their operations as a result of the COVID-19 outbreak.
Increasing burden of colorectal and bladder cancer in the North America region is also boosting the market growth. For instance, as per the estimates reported by the GLOBOCAN data, in the United States there were around 155,008 (6.8%) new colorectal cancer cases in 2020. Similarly, in Canada, there were around 25,510 (9.3%) new colorectal cancer cases and 9,350 (3.4%) new bladder cancer cases in 2020.
In addition, irritable bowel syndrome (IBS) is one of the most diagnosed gastrointestinal diseases. According to the American College of Gastroenterology, in 2019, in the United States, it was estimated that 10-15% of the adult population suffers from irritable bowel syndrome symptoms, yet only 5-7% of adults have been diagnosed with the disease.
Furthermore, increasing investments in the medical devices sector and the existence of various favorable policies of reimbursements are further stimulating the progress of the market for ostomy drainage bags, in the North America region. Hence, owing to above mentioned factors it is expected to drive the market growth over the forecast period.
The Ostomy Drainage Bags market is fragmented competitive. Some of the segments are dominated by a few major players, while the other segments are distributed among multiple players. The market players are moreover, focusing on collaboration and partnership activities. Some of the market players include Alcare Co. Ltd, B Braun Melsungen AG, Coloplast AS, ConvaTec Inc., Flexicare Medical Ltd, among others.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Increasing Incidence of Inflammatory Bowel Disease and Crohn's Disease
4.2.2 Rapidly Growing Aging Population
4.2.3 Rising Colorectal and Bladder Cancer Cases
4.3 Market Restraints
4.3.1 Reimbursement Issues
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Colostomy Bags
5.1.2 Ileostomy Bags
5.1.3 Urostomy Bags
5.1.4 Other Ostomy Types
5.2 By End User
5.2.2 Home Care Setups
5.2.3 Other End Users
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East and Africa
5.3.5 South America
126.96.36.199 Rest of South America
6.1.1 Alcare Co. Ltd
6.1.2 B.Braun Melsungen AG
6.1.3 Coloplast A/S
6.1.4 ConvaTec Inc.
6.1.5 Flexicare Medical Ltd
6.1.6 Marlen Manufacturing & Development
6.1.7 Pelcin Healthcare Ltd
6.1.8 Salts Healthcare Ltd
6.1.9 Torbot Group Inc.
6.1.10 Welland Medical Ltd
6.1.11 Prowess Care
6.1.12 Goodhealth Inc.
6.1.13 Oakmed Healthcare